A citation-based method for searching scientific literature

Sabari Nath Neerukonda, Russell Vassell, Carol D Weiss. Vaccines (Basel) 2020
Times Cited: 16







List of co-cited articles
101 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.
Antonietta Impagliazzo, Fin Milder, Harmjan Kuipers, Michelle V Wagner, Xueyong Zhu, Ryan M B Hoffman, Ruud van Meersbergen, Jeroen Huizingh, Patrick Wanningen, Johan Verspuij,[...]. Science 2015
369
50

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.
Hadi M Yassine, Jeffrey C Boyington, Patrick M McTamney, Chih-Jen Wei, Masaru Kanekiyo, Wing-Pui Kong, John R Gallagher, Lingshu Wang, Yi Zhang, M Gordon Joyce,[...]. Nat Med 2015
420
43


A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
Davide Corti, Jarrod Voss, Steven J Gamblin, Giosiana Codoni, Annalisa Macagno, David Jarrossay, Sebastien G Vachieri, Debora Pinna, Andrea Minola, Fabrizia Vanzetta,[...]. Science 2011
865
37

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.
Florian Krammer, Natalie Pica, Rong Hai, Irina Margine, Peter Palese. J Virol 2013
294
31

Antibody recognition of a highly conserved influenza virus epitope.
Damian C Ekiert, Gira Bhabha, Marc-André Elsliger, Robert H E Friesen, Mandy Jongeneelen, Mark Throsby, Jaap Goudsmit, Ian A Wilson. Science 2009
982
31

Highly conserved protective epitopes on influenza B viruses.
Cyrille Dreyfus, Nick S Laursen, Ted Kwaks, David Zuijdgeest, Reza Khayat, Damian C Ekiert, Jeong Hyun Lee, Zoltan Metlagel, Miriam V Bujny, Mandy Jongeneelen,[...]. Science 2012
540
31

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
A Danielle Iuliano, Katherine M Roguski, Howard H Chang, David J Muscatello, Rakhee Palekar, Stefano Tempia, Cheryl Cohen, Jon Michael Gran, Dena Schanzer, Benjamin J Cowling,[...]. Lancet 2018
25

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.
Vamsee V A Mallajosyula, Michael Citron, Francesca Ferrara, Xianghan Lu, Cheryl Callahan, Gwendolyn J Heidecker, Siddhartha P Sarma, Jessica A Flynn, Nigel J Temperton, Xiaoping Liang,[...]. Proc Natl Acad Sci U S A 2014
134
25

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.
David J DiLillo, Peter Palese, Patrick C Wilson, Jeffrey V Ravetch. J Clin Invest 2016
269
25

Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.
Lei Deng, Teena Mohan, Timothy Z Chang, Gilbert X Gonzalez, Ye Wang, Young-Man Kwon, Sang-Moo Kang, Richard W Compans, Julie A Champion, Bao-Zhong Wang. Nat Commun 2018
99
25

A highly conserved neutralizing epitope on group 2 influenza A viruses.
Damian C Ekiert, Robert H E Friesen, Gira Bhabha, Ted Kwaks, Mandy Jongeneelen, Wenli Yu, Carla Ophorst, Freek Cox, Hans J W M Korse, Boerries Brandenburg,[...]. Science 2011
629
25

The biology of influenza viruses.
Nicole M Bouvier, Peter Palese. Vaccine 2008
557
18

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
I Margine, F Krammer, R Hai, N S Heaton, G S Tan, S A Andrews, J A Runstadler, P C Wilson, R A Albrecht, A García-Sastre,[...]. J Virol 2013
155
18

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
Emily J Erbelding, Diane J Post, Erik J Stemmy, Paul C Roberts, Alison Deckhut Augustine, Stacy Ferguson, Catharine I Paules, Barney S Graham, Anthony S Fauci. J Infect Dis 2018
236
18

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, David I Bernstein, Jeffrey Guptill, Emmanuel B Walter, Franceso Berlanda-Scorza, Daniel Stadlbauer, Patrick C Wilson, Teresa Aydillo,[...]. Nat Med 2021
94
18



Stalking influenza by vaccination with pre-fusion headless HA mini-stem.
Sophie A Valkenburg, V Vamsee Aditya Mallajosyula, Olive T W Li, Alex W H Chin, George Carnell, Nigel Temperton, Raghavan Varadarajan, Leo L M Poon. Sci Rep 2016
90
18

Influenza virus vaccine based on the conserved hemagglutinin stalk domain.
John Steel, Anice C Lowen, Taia T Wang, Mark Yondola, Qinshan Gao, Kester Haye, Adolfo García-Sastre, Peter Palese. mBio 2010
412
18

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
Kizzmekia S Corbett, Syed M Moin, Hadi M Yassine, Alberto Cagigi, Masaru Kanekiyo, Seyhan Boyoglu-Barnum, Sky I Myers, Yaroslav Tsybovsky, Adam K Wheatley, Chaim A Schramm,[...]. mBio 2019
56
18

The influenza virus hemagglutinin head evolves faster than the stalk domain.
Ericka Kirkpatrick, Xueting Qiu, Patrick C Wilson, Justin Bahl, Florian Krammer. Sci Rep 2018
99
18

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.
Gayathri Bommakanti, Michael P Citron, Robert W Hepler, Cheryl Callahan, Gwendolyn J Heidecker, Tariq Ahmad Najar, Xianghan Lu, Joseph G Joyce, John W Shiver, Danilo R Casimiro,[...]. Proc Natl Acad Sci U S A 2010
175
18

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.
Damian M Carragher, Denise A Kaminski, Amy Moquin, Louise Hartson, Troy D Randall. J Immunol 2008
211
18

M2e-Based Universal Influenza A Vaccines.
Lei Deng, Ki Joon Cho, Walter Fiers, Xavier Saelens. Vaccines (Basel) 2015
107
18

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
Yao-Qing Chen, Teddy John Wohlbold, Nai-Ying Zheng, Min Huang, Yunping Huang, Karlynn E Neu, Jiwon Lee, Hongquan Wan, Karla Thatcher Rojas, Ericka Kirkpatrick,[...]. Cell 2018
207
18



Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
Christine B Turley, Richard E Rupp, Casey Johnson, David N Taylor, Julie Wolfson, Lynda Tussey, Uma Kavita, Lawrence Stanberry, Alan Shaw. Vaccine 2011
214
18

mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
18


Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.
H Keipp Talbot, Michael T Rock, Casey Johnson, Lynda Tussey, Uma Kavita, Anita Shanker, Alan R Shaw, David N Taylor. PLoS One 2010
58
18

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.
Min-Chul Kim, Yu-Na Lee, Hye Suk Hwang, Young-Tae Lee, Eun-Ju Ko, Yu-Jin Jung, Min Kyoung Cho, Yu-Jin Kim, Jong Seok Lee, Suk-Hoon Ha,[...]. Vaccine 2014
29
18

Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.
Min-Chul Kim, Jae-Min Song, Eunju O, Young-Man Kwon, Youn-Jeong Lee, Richard W Compans, Sang-Moo Kang. Mol Ther 2013
120
18


A universal influenza A vaccine based on the extracellular domain of the M2 protein.
S Neirynck, T Deroo, X Saelens, P Vanlandschoot, W M Jou, W Fiers. Nat Med 1999
567
18

M2-based influenza vaccines: recent advances and clinical potential.
Annasaheb Kolpe, Bert Schepens, Walter Fiers, Xavier Saelens. Expert Rev Vaccines 2017
74
18

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Himal Lal, Anthony L Cunningham, Olivier Godeaux, Roman Chlibek, Javier Diez-Domingo, Shinn-Jang Hwang, Myron J Levin, Janet E McElhaney, Airi Poder, Joan Puig-Barberà,[...]. N Engl J Med 2015
686
18

Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
Min-Chul Kim, Jong-Seok Lee, Young-Man Kwon, Eunju O, Youn-Jeong Lee, Jun-Gu Choi, Bao-Zhong Wang, Richard W Compans, Sang-Moo Kang. Antiviral Res 2013
57
18


The genomic rate of molecular adaptation of the human influenza A virus.
Samir Bhatt, Edward C Holmes, Oliver G Pybus. Mol Biol Evol 2011
106
12

Novel correlates of protection against pandemic H1N1 influenza A virus infection.
Sophia Ng, Raffael Nachbagauer, Angel Balmaseda, Daniel Stadlbauer, Sergio Ojeda, Mayuri Patel, Arvind Rajabhathor, Roger Lopez, Andrea F Guglia, Nery Sanchez,[...]. Nat Med 2019
84
12

Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
Joan E M van der Lubbe, Johan W A Verspuij, Jeroen Huizingh, Sonja P R Schmit-Tillemans, Jeroen T B M Tolboom, Liesbeth E H A Dekking, Ted Kwaks, Börries Brandenburg, Wim Meijberg, Roland C Zahn,[...]. Front Immunol 2018
19
12

The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.
Jong-Soo Lee, Mohammed Y E Chowdhury, Ho-Jin Moon, Young-Ki Choi, Melbourne R Talactac, Jae-Hoon Kim, Min-Eun Park, Hwa-Young Son, Kwang-Soon Shin, Chul-Joong Kim. J Virol Methods 2013
24
12

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Irina Isakova-Sivak, Victoria Matyushenko, Tatiana Kotomina, Irina Kiseleva, Elena Krutikova, Svetlana Donina, Andrey Rekstin, Natalia Larionova, Daria Mezhenskaya, Konstantin Sivak,[...]. Vaccines (Basel) 2019
14
14

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, Raffael Nachbagauer, Francesco Berlanda-Scorza, Jodi Feser, Patrick C Wilson, Alicia Solórzano, Marie Van der Wielen, Emmanuel B Walter,[...]. Lancet Infect Dis 2020
69
12

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice.
Susan Thrane, Kara-Lee Aves, Ida E M Uddbäck, Christoph M Janitzek, Julianna Han, Yuhe R Yang, Andrew B Ward, Thor G Theander, Morten A Nielsen, Ali Salanti,[...]. Vaccines (Basel) 2020
11
18

Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.
Gayathri Bommakanti, Xianghan Lu, Michael P Citron, Tariq Ahmad Najar, Gwendolyn J Heidecker, Jan ter Meulen, Raghavan Varadarajan, Xiaoping Liang. J Virol 2012
63
12

Influenza virus hemagglutinin stalk-based antibodies and vaccines.
Florian Krammer, Peter Palese. Curr Opin Virol 2013
239
12

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.
Florian Krammer, Rong Hai, Mark Yondola, Gene S Tan, Victor H Leyva-Grado, Alex B Ryder, Matthew S Miller, John K Rose, Peter Palese, Adolfo García-Sastre,[...]. J Virol 2014
113
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.